Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

OKYO

OKYO Pharma Ltd

CIK 0001849296 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.54
↑ 0.02 (1.32%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$80.82M
P/E Ratio
-17.17
EPS
-0.20
Dividend Yield
Not covered
52W Position
11%
Beta
1.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 11%
$1.34$3.20

Latest Financials

2025-03-31 FY
Revenue
–
Net Income
-$4.71M
Total Assets
$3.68M
Free Cash Flow
-$1.81M

Recent news